Enroflox 100, generic Baytril, enrofloxacin, is an injectable solution indicated for the treatment of bovine respiratory disease (BRD) in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine. Each ml of Enroflox 100 Injectable Solution contains 100 mg enrofloxacin. Enroflox 100 provides flexible doses and durations of therapy. Do not administer within 28 days of slaughte
Generic Baytril. Contains enrofloxacin, a broad-spectrum fluoroquinolone antimicrobial agent for cattle and swine. For therapeutic treatment, give a single doese for one day in swine and multiple days in cattle. In swine, Enroflox 100 is indicated for the treatment and control of swine respiratory disease (SRD) associated with actinobacillus pleuropheumoniae, Pastuerella multocida, H. parasuis and streptococcus suis. In cattle, Enroflox is used to treat bovine respiratory disease (BRD) associated with m. haemolytica, Pastuerella multocida and histophilus somni. Approved for use in beef and non-lactating dairy cattle. Enroflox withdrawal period is 28 days for cattle and 5 days for swine.
Features of Generic Baytril For Cattle
Same active ingredient and dosing schedule as Baytril® 100
Each ml of Enroflox contains 100mg of active ingredient enrofloxacin.
Easy to inject
Safe and effective
Used as single-dose treatment in swine.
Used as multi-day treatment in cattle.
Specifications of Generic Baytril For Cattle
Protect from direct sunlight.
Do not refrigerate or freeze.
Store below 77°F (25°C).
Precipitation may occur due to cold temperature. To redissolve, warm and then shake the vial.
Cattle intended for human consumption must not be slaughtered within 28 days from the last treatment. Do not use in calves to be processed for veal.
Swine intended for human consumption must not be slaughtered within 5 days of receiving a single-injection dose.
Baytril® 100 provides flexible dosages and durations of therapy. Baytril® 100 may be administered as a single dose for one day (cattle and swine) or for multiple days (cattle) of therapy. Selection of the appropriate dose and duration of therapy should be based on an assessment of the severity of disease, pathogen susceptibility and clinical response.
Single-Dose Therapy: Administer once, a subcutaneous dose of 7.5 – 12.5 mg/kg of body weight (3.4 – 5.7 mL/100 lb). Multiple-DayTherapy: Administer daily, a subcutaneous dose of 2.5 – 5.0 mg/kg of body weight (1.1 – 2.3 mL/100 lb). Treatment should be repeated at 24-hour intervals for three days. Additional treatments may be given on Days 4 and 5 to animals that have shown clinical improvement but not total recovery.
Administered dose volume should not exceed 20 mL per injection site.